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Abstract: Uncontrolled type 1 diabetes puts adolescents at an increased risk for cardiovascular 
disease, retinopathy, neuropathy, reduced brain mass, and reduced life expectancy among other 
symptoms. Clinically, behavioral interventions are staged for patients with uncontrolled type 1 
diabetes. Meta-analyses of these interventions have yielded non-significant differences in overall 
glycemic control, and have yet to identify any significant moderators of outcomes. The goal of 
this study was to update and improve upon past meta-analyses, and evaluate potential 
moderators. 28 RCTs of behavioral interventions in type 1 diabetes evaluating glycemic control 
were identified. Variables within interventions were collected and reviewed systematically, 
separating interventions into groups based on operational intensity, and time investment. 
Significant differences in effect size between groups separated by intervention administrator, 
training of administrators, and contact time were observed, marking those variables as potential 
effect moderators. However, more stringent meta-analytic tests concluded no evidence for 
moderation by any of the identified variables. Future studies regarding the science of 
intervention development should aim to limit demographic variance, and identify articles with 
large sample sizes, in order to discover significant moderators in improving glycemic control 
within behavioral type 1 diabetes interventions.  
 
Type 1 diabetes is a chronic and incurable disease wherein the pancreas does not produce 
insulin, a hormone that helps regulate the level of glucose in the blood5. Uncontrolled diabetes in 
pediatric patients is generally defined as having a hemoglobin A1c (HbA1c) greater than 9.5% 64, 
although specific targets vary by age. HbA1c is the measure of hemoglobin in red blood cells 
that are attached to glucose. Given the longer life span of red blood cells (~120 days), the HbA1c 
is effectively a measure of average blood glucose over a period of ~3 months. This measurement 
has been historically established as the primary indicator of diabetes, although it may not be 
wholly reliable74. 
  The rates of Type 1 diabetes are increasing world wide50, it is the third most common 
chronic illness in teenagers52, and afflicted adolescents display the worst glycemic control 
compared to other age-groups3, 11, 21, 27, 57 due to a variety of demographically unique social, 
familial, and developmental stressors27, 31, 38, 47. Poor glycemic control among these adolescents 
can reduce their life expectancy by up to 15 years compared to same-age healthy individuals61, 20, 
negatively affects their emotional well being39, is associated with vast medical-resource usage 
and healthcare expenses53, 54, is associated with adolescents’ psychiatric comorbidities8, and 
tends to persist into young adulthood7. Even a single episode of ketoacidosis (caused by 
prolonged hyperglycemia) is associated with lower cognitive functioning and reduction in brain 
mass in young children87. The favorable management of these adolescents’ glycemic control can 
prevent both serious and long-term medical complications (severe hypoglycemia, ketoacidosis, 
retinopathy, nephropathy, neuropathy, cardiovascular disease)85, 69, 20. 
Adolescents are an at-risk population for Type 1 diabetes because it requires continuous 
attention to care plans established by specialized diabetic endocrinologists or healthcare 
providers55. Social, familial, and developmental stressors in adolescents’ lives lead to their low-
adherence to care plans27, 31, 39, 48. Psychologists, physicians, and diabetic endocrinologists often 
work together to intervene in situations where diabetes is uncontrolled by adjusting the behavior 
of patients, their parents/support system, and/or healthcare providers. Research on medical 
interventions into the treatment of chronic-diseases has found that personable, communication-
driven, patient-clinician relationships improve disease outcomes88. Type 1 Diabetes related 
behavioral interventions present a uniquely complicated intersection of obstacles, mixing the 
chronic, intensive care required of diabetes with the complex developmental phase of 
adolescence. The structure, targets, goals, duration, and populations of these interventions can 
differ14. Research suggests stronger outcomes for psychological versus educational 
interventions72, and outlines factors within strong intervention that effectively promote self-
management9. Such results indicate that more engagement, or time investment in an intervention, 
could be related to its success. However, previous meta-analyses of behavioral type 1 diabetes 
interventions have not found significant results in improving glycemic control, or significant 
moderators of outcomes9, 13, 25, 33, 51, 72, 83.  
There is not yet a comprehensive meta-analysis of all prior behavioral interventions into 
adolescent Type-1 diabetic glycemic control. Furthermore, prior meta-analyses have been limited 
in their analysis of potential moderator effects. The present paper attempts to address both of 
these concerns to advance future research.   
Methods:  
 
A review of existing literature across databases PubMed, Cochrane Library, PSYCHInfo, 
Research Gate, Elsevier, NIH, and Google Scholar was conducted for the following: 
Interventions related to the glycemic control of Type 1 diabetic adolescents who have been 
diagnosed for >6mo, and that measured HbA1c at baseline and follow-up after 6-15 months 
(keywords used: “Type 1 diabetes,” “RCT,” “intervention,” “pediatrics,”). This search yielded 
315 results. Articles were then screened for their adherence to PRISMA guidelines for meta-
analyses67. 73 articles were selected for reading based on title relevance and abstract screening, 4 
were duplicates, and 6 were meta-analyses or systematic reviews. Selection criteria was 
indiscriminate of behavioral intervention style or population subset. After review, 28 RCT’s of 
behavioral Type 1 diabetes interventions were identified, detailing 35 separate interventions. 
Data collected included every operational variable identified in the articles, as well as 
demographic information. An inductive analysis of the articles revealed 4 potential moderator 
variables, which are described and operationalized below: Intervention style, degree of 
intervention administrator, length of training for intervention administrator, and contact time 
with adolescents.  
 
Intervention Style: 
Six different styles of intervention were identified, with some studies involving multiple 
styles: (1) education only; (2) behavioral therapy; (3) motivational interviewing; (4) behavioral 
family systems training; (5) case management; and (6) multi-systems therapy. Guided by 
Deborah Christie’s work14, intervention style was coded dichotomously as either ‘0’/less 
intensive (Styles 1-3, above) or ‘1’/more intensive (Styles 4-6, above).  
 
Degree of Intervention Administrator: 
Interventions were administered by people with varying levels of academic degrees, 
which is a proxy for level of qualification. Intervention administrator was coded dichotomously 
as either ‘0’/less qualified (i.e., people without post-doctoral training or medical degrees, such as 
nurses and some clinicians) or ‘1’/more qualified (i.e., people with post-doctoral training or a 
relevant medical degree, such as physicians, therapists, or Ph.D.-holding intervention 
developers).  
 
Length of Training for Intervention Administrator: 
The training of administrators regarding how to implement interventions varied in terms 
of length of time. Length of training for intervention administrator was coded dichotomously as 
either ‘0’/less time (i.e., administrators given < 5 hours of in-person training, or who relied solely 
on literature) or ‘1’/more time (i.e., ≥ 5 hours of in-person training).  
 
Length of Contact Time with Adolescents 
Interventions involved varying amounts of total intervention-contact time with 
adolescents, which was comprised of: (1) the frequency with which administrators met with 
patients (e.g., per week, month); (2) the duration of each meeting (e.g., minutes, hours); and (3) 
the duration of the entire intervention (e.g., 6 months, 12 months). For each intervention, these 
data were used to a total length of contact time with adolescents (in minutes). According to a 
median split, length of contact time with adolescents was coded dichotomously as either ‘0’/less 
time (i.e., < 540 minutes) or ‘1’/more time (i.e., ≥ 540 minutes).  
 
Systematic Review 
A systematic review was conducted by running t-tests on each intervention result (i.e., 
change in HbA1c and effect size r) according to the dichotomous moderator groups described 
above. While there were no significant differences for Intervention Style (Table B), for the 
variables of Intervention Administrator (Table C), Training of Administrators (Table D), and 
Contact Time (Table E), the ‘more intense’ groups (e.g. 1’s) were significantly associated with a 
decrease in HBA1c change and an increase in effect size r. 
These three variables – Intervention Administrator, Training of Administrators, and 
Contact Time – were then used to generate an ordinal, overall ‘intensity’ score for each 
individual intervention. Specifically, each individual intervention was assigned 1 point for each 
of these three variables when they were ‘more intense’ (vs. ‘less intense’) in that intervention. As 
a result, each individual intervention was assigned a 0-3 score. Interventions were then 
dichotomized into two groups: ‘more intense’ (a score of 2-3) and ‘less intense’ (a score of 0-1).  
A t-test showed that, compared to ‘less intense’ interventions, ‘more intense’ 
interventions were significantly associated with a decrease in HBA1c change and an increase in 
effect size r (Table F). 
 
Meta-Analysis 
The meta-analysis was conducted using Hunter-Schmidt Meta-Analysis Programs73. The 
Hunter-Schmidt method37 assumes a random-effects model. This effect compares the change 
seen in the experimental group to the change seen in the control group. This comparison is the 
strongest test of the effect, as it accounts for changes in control group that may indicate threats to 
validity (e.g., history effects, maturation). A total of n = 27 effect sizes were extracted from the 
literature. The total meta-analysis sample size was N = 1751, with a mean sample size per 





Demographic characteristics of this study  
Number of youths identified in studies 2,418 
Average age 13.9 
Average diabetes duration 6 years 
Average baseline A1c 9.46 (1.04) 
Average follow-up A1c 9.24 (0.90) 









Results of Systematic Review: 
 
Table B:     *=significant result difference at 0.05 confidence level 
Intervention style Change in A1c Average effect (r) 
0 (n=17) -0.181764706 -0.055699789 
1 (n=18) -0.262777778 -0.069294669 
ttest 0.618567873 0.800266922 
 
Table C: 
Intervention administrators Change in A1c Average effect (r) 
0 (n=19) -0.068947368 -0.016360484 
1 (n=16) -0.406875 -0.117709453 





Change in A1c Average effect (r) 
0 (n=16) -0.020625 -0.007375427 
1 (n=19) -0.394210526 -0.109273348 








Contact Time Change in A1c Average effect (r) 
0 (n=18) -0.029444444 -0.002689037 
1 (n=17) -0.428823529 -0.126223399 
ttest *0.010867236 *0.016480113 
 
Table F: 
Sum of variables with 
significant differences 
Change in A1c Average effect (r) 
sum 0-1 (n=20) 0.017 0.013671689 
sum 2-3 (n=15) -0.544 -0.164508949 
ttest *0.000293242 *0.000362056 
 
 
To confirm these significant results, Intervention Administrator, Training of 
Administrators, and Contact Time were explored as intervention effect moderators through a 
more stringent, meta-analytic test.  
 
Results of Meta-Analysis: 
The meta-analysis indicated that interventions had a marginally significant effect on A1c 
levels relative to control groups. The observed mean effect size was r = .07 (observed SD = .13), 
d = .14, and the sample-size weighted mean correlation was ρ = .04, (SDρ = .10, 95% CI [-.00, 
.07], 80% Credibility Interval [-.09, .16]), δ = .08. The results also indicated that 100% of the 
variance in effect sizes was due to sampling error, indicating that there were no moderators of 
this effect. However, this sampling error calculation assumes independent groups, and thus 
overestimates the true sampling error for a repeated measures design73.  
Adjusting the sample size to account for the lower levels of sampling error resulted in an 
adjusted total sample size of N = 40,021 (mean N = 1482). Using the adjusted sampling error 
calculations, the sample-size weighted mean effect size was not statistically significant, ρ = .02 
(SDρ = .09, 95% CI [-.01, .05], 80% Credibility Interval [-.09, .13]), δ = .04. In this case, 
however, the results indicated that sampling error could account for only 8.99% of the variance 
in effect sizes, indicating other artifacts and/or moderators exist, as proposed by the systematic 
review. 
No corrections for other artifacts were performed. Studies indicate that A1c measures 
have a test-retest reliability of approximately r = .93, which is quite high74. All of the studies use 
the same measure of HbA1c, so this artifact cannot explain additional variance in effect sizes. 
Analyses of potential moderators Intervention Administrator, Training of Administrators, 
and Contact Time, as well as the other proposed non-significant moderators; Intervention style, 
baseline A1c, average patient age at baseline, and intervention delivery in groups of patients 
(y=1 or n=0), were conducted in an attempt to explain additional variance in effect sizes. 
 
Table G: 
Intervention Administrator 1 0 
Weighted mean effect size 
(SD) 
0.09 0.01 
95% CI [0.03-0.15] [-0.03-0.05] 
 
Table H: 
Training of administrators 1 0 
Weighted mean effect size 
(SD) 
0.08 <-0.01 





Contact time 1 0 
Weighted mean effect size 
(SD) 
0.05 0.01 
95% CI [-0.01-0.11] [-0.03-0.05] 
 
 
None of the proposed moderators were able to explain additional variance. In many cases 
the credibility intervals for groups overlap (Tables G, I, and moderators not shown), and the 
percentage of variance explained increased minimally. The Training of Administrators 
moderator (Table H) saw a difference in effect size, but the credibility intervals still constitute 
minimal overall effect, even at the upper range, and the variable explained little additional 
variance (8.99% -> 15.92%), suggesting no evidence for moderation by this variable. The same 
analyses were conducted on a second set of studies, which were representative of repeated 
measure designs with no classical control group 23, 30, 79, and the results were virtually identical. 
 
 Discussion: Interventions in type 1 diabetes for juvenile patients are incredibly important 
in avoiding acute and chronic health complications20, 69, 85, 87, 8. Between ages 12-18, type 1 
diabetics see significant increases in HbA1c55. These interventions cost providers time, staff, and 
resources, and thus constitute significant investment, even at low levels of engagement. This 
makes it increasingly frustrating and wasteful when interventions do not provide desired results. 
In the systematic review, significant outcome differences within the administrator-training and 
contact-time variables suggest that resource investment is directly correlated with better 
glycemic outcomes in patients. This finding should incentivize and provide justification for the 
development of more ‘hands-on’ and involved interventions. Despite the fact that studies 
produced moderate effect sizes without meeting the outlined criteria45, and others found no 
results while meeting criteria66, 80, the systematic analysis suggests that administrators, 
administrator training, and contact time are related to positive intervention outcomes. However, 
the meta-analytic data suggests no significant relationship between any of the variables and 
improved glycemic outcomes. This lack of findings is possibly explained by sampling error 
and/or publication bias.  
One  reason why the meta-analytic weightings and adjustments diluted significant results 
may involve interventions’ low sample sizes, which likely contributed to a wide range in 
standard deviations for changes in glycemic scores. Low sample sizes are likely due to the 
expense associated with intervention expenses. For instance, larger sample sizes mandate 
increased, and thus costly, healthcare resources (e.g., time of providers, technicians, and 
specialists, increased materials, etc.). The pressure to keep costs down incentivizes: (1) 
interventions with lower sample sizes; and/or (2) interventions that are less ‘intense.’ In both of 
these cases, the potential for interventions’ success, and the meta-analytic ability to adequately 
assess this success, is diminished. In sum, rather than concluding that interventions are non-
efficacious, it might be concluded that the 35 interventions examined do not accurately reflect 
the research community’s strongest intervention efforts.   
Economic analyses of interventions should be conducted in order to justify them (or not).  
For example, quality interventions, although expensive to conduct, may actually result in cost 
savings when their longer-term healthcare benefits are considered, such as reducing patients’ 
healthcare usage (and thus reducing testing and medication costs, etc.). Modern interventions 
utilizing technology like Skype have shown great promise in creating hands-on interventions that 
require less investment30.  
Perhaps the biggest source of error, across all analyses of diabetic interventions, comes 
from how HbA1c change is conceptualized. Currently, all HbA1c changes are considered to be 
equivalent and thus comparable. However, patients’ ability to reduce A1c is affected by their 
baseline A1c levels. For example, it is easier for diabetics to reduce their A1c from 12mmol/mol 
to 10mmol/mol than it is from 10mmol/mol to 8mmol/mol, suggesting that HbA1c changes are 
not equivalent and comparable. Future studies examining HbA1c change need to develop a 
logarithmic adjustment in order to statistically account for this fact.  
Future research also needs to pay more attention to patient demographics. Intervention 
participants’ families are largely low-to-middle class, and socio-economic status likely affects 
patients’ abilities to control diabetes68. Intervention participants are also overwhelmingly 
Caucasian, and we know that rates and levels of diabetes vary along cultural lines14, 6, 4. 
 
How to move forward 
 
I think the field, and its inherent problems in finding significant results with meta-
analytic power, relate to the eclectic nature of palliative interventionism as an imperfect science. 
Diabetic interventions, for example, are much more relevant to clinical endocrinology than they 
are to retrospective research into the science of their development and composition. These 
interventions cannot be tested in vitro or in mice. Pilot study or borne out psychosocial 
methodology, these interventions are implemented in clinical diabetes care with real patients to 
which they will have real effects on their healthcare and well-being. Once an intervention is 
shown to have significant results via pilot study and receives funding for implementation, it’s 
active. There’s no longer an ethical justification for the kind of randomized controlled trial that’s 
included in these analyses, where some patients are randomized to a non-treatment group. “X” is 
shown to work, so in a clinical setting it gets put to use, not many additional studies are 
conducted to see if “X” is still working, unless they’re given a reason to believe it isn’t.  
Additionally, with healthcare interventions, results are much more likely to be treated as 
subjected to the individual, not failures of the intervention. Thus, for many interventions, 
longitudinal studies with bigger populations are hard to justify, and conduct. Therefore, the 
obstacle these diabetic intervention meta-analyses run into with low effect sizes, high sampling 
error, are very difficult to overcome.  
I think that future meta-analyses in pediatric type 1 diabetes can address inherent 
obstacles through inclusion criteria. Trying to control for as many variables as possible like 
socioeconomic status, family structure, etc. reduces confounding moderators. Also, consideration 
should be given to non-RCT publications that evaluate large scale utilization of certain 
interventions. Perhaps clinical standards, or HbA1c trends by age31, 55 could be utilized like 
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